WebDisclosure WebDisclosure
Basculer en Français
10612 Companies
225255 Keywords
153902 Articles
119178 Press releases
Headlines Articles Press releases Piramal Pharma Solutions Remove
  1. Home
  2. Companies
  3. Piramal Pharma Solutions
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/30/2025 at 06:30, 7 months 23 days ago

    Piramal Pharma Solutions Partners with IntoCell to Enhance Bioconjugate Capabilities

    ADC Development Pharmaceutical Collaboration Piramal Pharma IntoCell Bioconjugates
  • BRIEF

    published on 10/30/2025 at 06:30, 7 months 23 days ago

    Piramal Pharma Solutions s'associe à IntoCell pour renforcer ses capacités en matière de bioconjugaison.

    Développement ADC Collaboration Pharmaceutique Piramal Pharma IntoCell Bioconjugués
  • PRESS RELEASE

    published on 10/30/2025 at 06:25, 7 months 23 days ago

    Piramal Pharma Solutions Formalizes Partnership with IntoCell, Expanding its Payload-Linker Platform and Bioconjugate Capabilities

    Piramal Pharma Solutions partners with IntoCell to enhance bioconjugate capabilities and ADC development. Strategic agreement strengthens competitive edge and accelerates bioconjugate services
    Partnership ADC Development IntoCell Piramal Pharma Solutions Bioconjugate
    Logo of Piramal Pharma Solutions
Previous page
1 ... 3 4
Accesswire
  • Published on 06/22/2026 at 15:58, 10 minutes ago

    Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement

  • Published on 06/22/2026 at 15:30, 38 minutes ago

    NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo

  • Published on 06/22/2026 at 15:00, 1 hour 8 minutes ago

    Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program

  • Published on 06/22/2026 at 14:01, 2 hours 7 minutes ago

    Worksport (NASDAQ:WKSP) Achieves 35% May Gross Margin, Lands Meyer Distribution, Targets $36M+ Revenue Run-Rate

  • Published on 06/22/2026 at 14:00, 2 hours 8 minutes ago

    Adcore Enters Strategic Partnership with TikTok as a Channel Sales Partner

View all ACCESSWIRE
EQS Group
  • Published on 06/22/2026 at 15:33, 34 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc

  • Published on 06/22/2026 at 15:32, 35 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc

  • Published on 06/22/2026 at 15:32, 36 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Senior plc

  • Published on 06/22/2026 at 15:31, 37 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Schroders plc

  • Published on 06/22/2026 at 15:30, 38 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: JTC plc

View all EQS
Les Echos
  • Published on 06/22/2026 at 14:42, 1 hour 25 minutes ago

    COMMUNIQUE HOPENING 22 juin 2026

  • Published on 06/22/2026 at 08:30, 7 hours 38 minutes ago

    Eiffage entre en négociation exclusive avec Atlas Arteria en vue d’acquérir la concession du tunnel de Warnow à Rostock, en Allemagne

  • Published on 06/22/2026 at 08:30, 7 hours 38 minutes ago

    Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany

  • Published on 06/19/2026 at 19:33, 2 days 20 hours ago

    Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026

  • Published on 06/19/2026 at 19:33, 2 days 20 hours ago

    Disclosure of transactions in own shares from June 15 to June 19, 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy